Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd.

Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), founded in the 14th year of the Guangxu reign of the Qing Dynasty (1888 AD), has for over 100 years upheld the eternal spirit of "working together with one heart to benefit and save lives," always adhering to the characteristics of traditional Chinese medicine and promoting its culture. The Company's registered capital is RMB 249,759,458, with over 1,100 employees. In 2008, the Company's traditional Chinese medicine culture was included in the "Intangible Cultural Heritage" list. In 2013, the Company joined China National Pharmaceutical Group as a third-tier subsidiary, covering businesses such as Chinese herbal medicine cultivation, proprietary Chinese medicines, Chinese medicine formula granules, Chinese herbal decoction pieces, traditional Chinese medicine clinics, and big health products for Chinese medicine, making it a full-industry-chain company in the traditional Chinese medicine sector.

The Company's orthopedic Chinese medicine production base in Guiyang Economic and Technological Development Zone covers an area of 272 mu, with a building area of 100,000 square meters. It has an annual production capacity of 10 billion oral solid dosage units, and when operating at full capacity, it will achieve an annual output value of 6 billion yuan. It is currently one of the leading production bases for Chinese medicine solid preparations in southwest China. Combining with Guizhou Province's "Thousand Enterprise Transformation, One Enterprise One Policy" initiative, the Company integrates traditional Chinese medicine production with modern intelligent equipment, establishing an advanced production line with full digital transmission and visualized production. This has created an innovative Chinese medicine enterprise with traditional characteristics, and it has been awarded the title of "Intelligent Manufacturing" demonstration unit by the Ministry of Industry and Information Technology.

The Company has established a Chinese herbal medicine seed breeding and research center, focusing on developing a standardized breeding system for herbs such as epimedium, providing high-quality seeds and seedlings for "customized medicinal gardens" of epimedium and other herbs, ensuring the safety, stability, quality, and controllability of medicinal materials from the source. The breeding center includes automated seedling greenhouses, experimental areas, traceability display areas, and a smart agriculture system control center. During the 14th Five-Year Plan period, the cultivation scale will be gradually expanded to promote the development of authentic and geographically indicative medicinal materials in Guizhou.